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Pyrimethamine efficacy was investigated in vitro on the blood asexual stages, the sexual stages 
and exflagellation in PlasmodiumJalciparum. Gametocytogenesis was stimulated following the 
standard methods on five isolates of Plasmodium Jalciparum. From these five isolates, RSA 
2, 3 and 5 produced gametocytes which reached maturity within seven days and the 
gametocytes were able to exflagellate. Isolate MW2 produced young gametocytes which 
disappeared within ten days. NF54 produced mature gametocytes which lasted for 24 hours 
only. 
There were no statistically significant differences between the static and the synchronization 
methods of gametocyte stimulation for any of the isolates. The effect of pyrimethamine was 
investigated by adding a known concentration of the drug (For RSA 2, MW2 and NF54, 
lOOnmolli; RSA 3 and 5, 3000nmolli pyrimethamine) to the culture medium for seven days 
during gametocyte stimulation. The results of this investigation show that there was 
gametocytocidal activity on the isolates that were used and pyrimethamine also had a 
schizontocidal action on NF54 and the young gametocytes of this isolate were destroyed by 
the drug. At concentrations which were inhibitory to asexual parasites, the drug had a 
sporontocidal effect on isolate RSA 2 but not on isolate RSA 5. The pyrimethamine MIC 
values for asexual parasites ranged from 300nmoll i to > 3000nmol/ i (RSA 2 and 5 were not 
inhibited at 3 OOOn mol/ f). These results are consistent with those found in previous studies 
when pyrimethamine resistance was first detected in South Africa. 
III 
The chloroquine MICs indicate a good correlation with the results obtained from previous drug 
sensitivity tests for all the isolates examined using both the 48-hour in vitro test and isotope 
incorporation for growth assessment. The isobolograms constructed to determine relationship 
between chloroquine and pyrimethamine indicated no synergism for isolates RSA 2 and 5, but 
the E relative ICsos indicated a weak synergism. Both the isobolograms and the E relative ICsoS 
for the isolates RSA 6, 9 and 14 indicated an antagonistic action between chloroquine and 
pyrimethamine. The results obtained from this study have important implications for malaria 
control in South Africa. 
IV 
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CHAPTER 1 
INTRODUCTION 
1.1 PLASMODIUM FALCIPARUM MALARIA IN SOUTH AFRICA 
1 
In South Africa at least 90 % of malarial infections are caused by Plasmodium Jalciparum 
(Newlands, 1989). There is a limited distribution of malaria in this part of the African 
continent (Strebel et al, 1990) and the endemic malarial areas are the North and Eastern 
Transvaal and KwaZulu-Natal, especially near the borders of Mozambique and Zimbabwe 
(Frean & Blumberg, 1993; Hansford, 1993; Ie Sueur et al., 1993) (Fig. 1- shows historical 
distribution of malaria, especially as modern borders of homelands are indicated). 
In the Transvaal over 70 % infections occur in the Barberton magisterial district. Most of 
these are found in the Malelane-Komatipoort sectors where intense irrigation is practised 
and to where a considerable proportion of farm workers migrate from Mozambique, 
Gazankulu, KaNgwane, Lebowa and Venda (Hansford, 1990). The main endemic area is 
KwaZulu-Natal. This is probably due to imported malaria via Mozambique migrants (about 
90% of imported cases) (Ngxongo, 1993). High incidence rates during 1987 and 1988 
occurred in the Ingwavuma and Ubombo districts where cases from these areas made up 
88% of the total number of cases for KwaZulu-Natal (Ngxongo, 1993) due partly to 
irrigation spillage in the Mamfene sector of Ubombo district (Hansford & Muller, 1990). 
Epidemiological studies carried out in the KwaZulu part of the KwaZulu-Natal province 
have revealed that many malarious areas have been cleared of malaria and that the disease 
is now confmed to the coastal region near the Mozambique border (Ngxongo, 1993). 
2 
FIG. L MALARIOUS AREAS OF THE UNION OF SOUTH AFRICA, 1938. 




































In South Africa malaria is transmitted mainly by Anopheles arabiensis and to some extent 
Anopheles merus (Sharp el al, 1984). Transmission is extremely variable from season to 
season (Frean & Blumberg, 1993; Hansford & Muller, 1990) and from locality to locality, 
being determined by various factors such as climate, human migration, environmental 
changes, agricultural development and changes in the malaria control policy (Frean & 
Blumberg, 1993). The majority of malaria cases (80%) are known to occur during the 
months January to June with peaks occurring in April to May (Ngxongo, 1993). 
The Malaria Control Programme in KwaZulu-Natal has reduced the incidence of malaria 
to low levels in comparison to those experienced during the fIrst three decades of this 
century (Fig. 1), due to the use of chemotherapeutic drugs and insecticides. Figure 2 shows 
the annual malaria case incidence from 1980 to 1991 in the Northern Natal Malaria Control 
Regions, the figures within parentheses indicate the number of places or polygons where 
cases were found (Ie Sueur & Ngxongo, 1994, unpublished). Hansford (1990) suggested 
that malaria control should be maintained essentially by a will to control, the availability 
of funds and the environmental planning. 
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FIG. 2. ANNUAL MALARIA CASE INCIDENCE FROM 1980 TO 1991 IN THE 
NORTHERN KW AZULU-NAT AL MALARIA CONTROL REGIONS- the numbers 
in parentheses refer to the number of places or polygons captured in the map. 
(Source: Ie Sueur & Ngxongo, 1994, unpublished). 
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1.2 LIFE CYCLE OF PLASMODIUM FALCiPARUM 
Plasmodiumfalciparum malaria is a more serious and dangerous disease than those caused 
by the other three species of the genus Plasmodium infecting man; P. o vale , P. vivax and 
P. malariae. The incubation period lasts from 8 to 20 days and may run an acute course 
which may result in death if urgent treatment is not provided (Ash & Orihel , 1984; 
Garnham, 1988; Olsen, 1974) . 
1.2.1 In the human host 
Plasmodium falciparum occurs in two phases; the pre-erythrocytic and the erythrocytic 
(blood) phases. The former takes place within parenchymal cells of the liver (Ash & 
Orihel , 1984; Garnham, 1988; and Olsen, 1974) . The sporozoites introduced via the 
mosquito ' s bite are carried to the blood stream, then escape into the adjacent hepatocytes 
where they commence the schizogonic cycle. The pre-erythrocytic schizogony lasts for 
about five-and-a-half days. The spherical schizonts change shape in the course of their 
growth and burst to release merozoites (Beaudoin et al, 1988; Garnham, 1988; Newlands, 
.1 989) . 
The blood phase starts when the merozoites enter the blood stream. Here each merozoite 
invades a red blood cell and develops into the asexual ring stage. The youngest rings are 
only 1.2/im in diameter. The ring stages tend to adhere to the surface of the erythrocyte 
and their nuclei are often divided. Amoeboid cytoplasmic strands, the trophozoites , grow 
out from the ring forms. 
8 
These trophozoites do not last very long, but can be readily observed in in vitro cultures 
of P. faiciparum (Carter & Miller, 1979; Jensen & Trager,1977). The next stage is the 
erythrocytic schizont which develops from the trophozoite. Schizogony can be observed 
in cultures where immature schizonts appear within 12 hours or even less (Gamham, 
1988). Schizonts contain a dark pigment and their nuclei divide several times forming 
merozoites which will either repeat the asexual stages or start the sexual cycle. After about 
eight to 10 days of asexual parasite growth, gametocytes, the sexual stages, appear. The 
early stages are almost triangular in shape with the longest side stretched into a bow and 
they appear as a spindle in later forms (Carter & Miller, 1979). 
Gametocyte development can be observed clearly in cultures maintained under appropriate 
laboratory conditions. Gametocyte development in in vitro cultures takes seven to 10 days, 
and they pass through five developmental stages (Carter & Graves, 1988; Ponnudurai et 
ai, 1986). These growth stages are classified according to their shape, pigment distribution 
and nuclear and cytoplasmic arrangement (Carter & Miller, 1979; Ponnudurai et ai, 1986). 
The first stage (Stage 1) takes about 24 hours to develop and is small and rounded. The 
parasite has a light staining nucleus and the cytoplasm is almost clear. The pigment is 
somewhat scattered within the parasite. 
Stage II gametocytes can he distinguished within the erythrocyte by their tear-drop shape. 
These appear after two days. Stage III has rounded ends and the red blood cells become 
distorted. Stage IV gametocytes, like Stage III. take 24 hours to appear. The parasite at 
this stage has its two ends pointed like a spindle and the pigment is darker than in the 
young gametocytes. 
9 
The tinal developmental stage at which the parasite reaches maturity is Stage V. This stage 
takes 48 hours to de~elop. During this stage the sex of the parasite can be clearly 
distinguished. The female gametocyte (macrogametocyte) is more elongate than the male 
gametocyte, the nuclear material is centrally arranged and the pigment is very dark. The 
staining appears bluish and the parasite is crescentic. The male gametocyte or 
microgametocyte has a stumpy form and is brownish-pink in colour. Pigment is scattered 
along the length of the parasite (Carter & Miller, 1979; Ponnudurai et ai, 1986). 
1.2.2 In the mosquito 
Further development of gametocytes takes place in the midgut of the mosquito. This 
happens only when mature gametocytes have been ingested by the mosquito. By a process 
called exflagellation, the male gametocytes produce microgametes. Macrogametocytes 
produce macrogametes by rounding up (Carter & Graves, 1988; Vanderberg, 1988). 
Exflagellation can be easily demonstrated by direct observation of wet mounted slide 
preparations under phase-contrast (Carter & Beach, 1977; Sinden, 1983; Sinden et ai, 
1984). 
Following fertilization of a macrogamete by a microgamete a zygote develops which is 
called an ookinete. The ookinete divides several times and undergoes further development 
before transforming into young spherical oocysts. Sporozoite differentiation takes place 
at the surfaces of the cytoplasmic masses known as sporoblasts, formed by the segregation 
of the oocyst interior. The process may take four to 21 days in vivo. Further development 
of the sporozoites occurs within the salivary glands of the mosquito (Vanderberg, 1988) 
from where they are ready to be passed into the human host following a blood meal. 
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1.3 MALARIA CONTROL 
Control of malaria in South Africa started as early as the 1930s when several experts were 
invited by the South African Government to assess and give advice on malaria 
(Swellengrebel, 1931). The complex life cycle of the malaria parasite makes control of the 
disease difficult. Malaria control involves the elimination of both the parasite and the 
mosquito vector. 
1.3.1 Parasite Control 
The are a number of factors to be considered in order to achieve successful parasite control 
and these include age of the patient, pregnancy and the tolerability of specific drugs (Frean 
& Blumberg, 1993). The species of Plasmodium to be treated and the developmental stage 
of the parasite are also important factors (Desjardins et ai, 1988). 
1 .3. 1 . 1 Asexual stages 
It has been long established that the chemotherapeutic drugs developed for controlling 
asexual stages in the life cycle of the parasite, cannot be effectively used against other 
stages of development. Therefore more drugs need to be tested both in vitro (Wemsdorfer 
& Payne, 1988) and clinically so as to wmpletely eradicate the parasites and their 
infections. There are several drugs that can be used for prophylaxis and treatment of 
asexual stages of the parasite. These have proved effective provided proper dosage and 
administration of the drugs are followed. One of the oldest drugs, quinine, is effective 
against all forms of malaria. 
.i 
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This drug kills the asexual blood stages as well as immature gametocytes of P. jaiciparum, 
and gametocytes of P. maiariae, P. ovaie and P. vivax (Black et ai, 1986; Myint & Shwe, 
1987; Newlands, 1989; White , 1988; WHO, 1982). However, quinine-resistant malaria 
has been reported in many parts of the world (Brasseur et ai, 1987; Giboda, 1987; 
Hellgren et ai, 1987; Ho et ai, 1987; Howells , 1986) including some southern African 
countries such as Malawi and Zambia (Freese et ai, 1994). A combined 
quinineitetracycline treatment was recommended for malaria in Thailand in the early 1980s 
(Wernsdorfer, 1991). In South Africa it was shown recently that there is reduced sensitivity 
of P. Jaiciparum to quinine in vitro (Freese et ai, 1994). 
Other antimalarials that can he used against the asexual blood stages of the parasite are; 
metloquine, chloroquine, amodiaquine, proguanil, doxycycline, halofantrine, 
pyrimethamine and qinghaosu (QHS) (Hoffman et ai, 1987; Wernsdorfer, 1986). 
According to Khaliq et ai (1987) and Peto & Gilks (1986), amodiaquine is no longer 
effective against Pfaiciparum in Punjab. Bjorkman & Phillips-Howard (1990) and 
Wernsdorfer (1991) confirmed the reports on amodiaquine-resistant malaria. Freese et ai 
(1994) suggested that amodiaquine would not he recommended for malaria chemotherapy 
in southern Africa due to growing evidence of resistance to it. Mefloquine was found to 
he highly effective against all the southern African isolates of P. Jaiciparum tested in vitro 
(Freese et ai, 1994) and this drug is used for both prophylaxis and treatment in South 
Africa. Metloquine is fairly well tolerated, but severe side effects such as dizziness , 
epigastric pain and vomiting may result from the use of high doses during treatment 
(Amhroise-Thomas & Rossignol , 1986; Dept. Nat. Health & Pop. Dev. , 1993; Edrissian 
et ai. 1987; Ho et ai, 1987) . 
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Menoquine should not be taken by pregnant women, persons with hypersensitivity to it, 
persons with neuropsychiatric or cardiac rhythm problems, babies or children weighing less 
than 15kg, pilots and others requiring fine or skilled co-ordination (Frean & Blumberg, 
1993). Mefloquine resistance has been established in Thailand (Bjorkman & hillips-
Howard, 1990; Wemsdorfer, 1991), Mozambique, Central, East Africa (Frean & 
Blumberg, 1993), Zambia (Lemnge & Inambao, 1990», Tanzania and most African 
countries (Bjorkman & Phillips-Howard, 1990). 
Doxycycline is an effective prophylactic drug especially to people visiting chloroquine-
resistant areas (Baker et ai, 1993), but the drug cannot be taken by pregnant women or 
children under eight years (Frean & Blumberg, 1993). Proguanil is safe for pregnant 
women and children (Dept. Nat. Health & Pop. Dev., 1993) but this drug is no longer 
recommended on its own in South Africa but should be taken in association with 
chloroquine (Baker et ai, 1993). Resistance to proguanil was established in the early 1950s 
and several reports have confirmed resistance to it in many parts of Africa (Bjorkman & 
Phillips-Howard, 1990). 
Chloroquine is another effective antimalarial against all forms of malaria particularly in 
those areas where no resistance to this drug has been reported (Baker et ai, 1993; Frean 
& Blumherg, 1993). Chloroquine is safe in pregnancy and for young children (Baker et ai, 
1993). The major problem with chloroquine is the development of resistance to it by the 
parasite. In southern Africa chloroquine-resistant falciparum malaria has heen confirmed 
(Freese et ai, 1988b; 1991; Herbst et ai, 1985; 1987; Heymann et ai, 1987; Sharp & 
Freese, 1990). 
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Present and previous reports (Deacon et ai, 1994; Isaacson et ai, 1984) have revealed that 
Transvaal isolates of P. faiciparum are also developing resistance to the drugs. 
Chloroquine-resistance has also become established in Cameroon in West Africa (Brasseur 
et ai, 1987; Geary et ai, 1987; Sinha & Gajanana, 1987) and in many parts of world 
especially, the southern hemisphere (Wernsdorfer, 1991). However, no evidence has been 
produced regarding the effectiveness of chloroquine on P.ovaie and P. maiariae 
(Wernsdorfer, 1991), but chloroquine-resistant P. vivax has been established in Papua New 
Guinea (Cooper, 1994). 
Halofantrine has proved to be effective against southern African isolates of P. faiciparum 
(Freese et ai, 1993) . This drug is known to have minimal side effects such as epigastric 
pain, vomiting and diarrhoea, and in certain predisposed individuals serious, including fatal 
in some cases have been reported. Halofantrine can be well tolerated (Ambroise-Thomas 
& Rossignol , 1986) and is the new drug under recommendation against the erythrocytic 
asexual stages of the parasite (Wernsdorfer, 1991). 
Qinghaosu (QHS) is reported to be active against chloroquine-resistant fa1ciparum malaria 
in China (Elford et ai, 1987). QHS and its derivatives were first isolated in 1971 from 
Artemisia annua , a plant used in traditional Chinese medicine for 1 500 years (Howells , 
1986) . Although there are no reports involving the use of QHS in South Africa, this drug 
has been used in other African countries (TOR, 1994) . Although drug-resistance is a 
problem for malaria chemotherapy, the use of drug combinations has been successful in 
many cases. 
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Fansidar (pyrimethamine/sulphadoxine) is still effective against chloroquine-resistant 
malaria (Watt et al, 1987; Wemsdorfer, 1986), though there has been reports about 
resistance to this drug compound in some parts of the world (Bjorkman & Phillips-Howard, 
1990; Watt et al, 1987; Wemsdorfer, 1991). In South Africa recent studies have revealed 
low sensitivities to Fansidar by the isolates of P. jaiciparum (Freese et ai, 1994) and this 
drug is no longer recommended for chemoprophylaxis by WHO because of severe side 
effects (Baker et ai, 1993). 
1 .3. 1.2 Sexual stages 
Young gametocytes are killed hy all schizontocidal drugs described above. Pyrimethamine 
is active against young gametocytes of P. jaiciparum but not against mature stages (Black 
et ai, 1986). Pyrimethamine is effective against mature gametocytes of P. vivax, P. ovaie 
and P. maiariae. (Black et ai, 1986; Desjardins et ai, 1988). Pyrimethamine is no longer 
recommended on its own since there is widespread resistance to this drug (Baker et ai, 
1993; Peters, 1987). In South Africa recent studies involving drug tests showed that 
pyrimethamine failed to inhibit schizont growth (Freese et ai, 1991). 
Primaquine and pamaquine are effective against mature gametocytes of P. jaiciparum. 
These two drugs are restricted to gametocytes circulating in the hlood stream and they do 
not affect gametogenesis, fertilization or sporogony (Meuwissen & Ponnudurai, 1988; 
Ponnudurai et al, 1989a). 
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1 .3. 1 .3 Sporogonic stages 
The major goal of using sporontocidal drugs is to prevent subsequent sporogonic stages in 
the mosquitoes after gametocytes have heen ingested. One such drug is proguanil but this 
drug is no longer recommended on its own in South Africa because of its widespread 
resistance (Baker et at, 1993). Cycloguanil, the active metabolite of proguanil, showed a 
sporontocidal activity against some sensitive strains of P. fatciparum (Teklehaimanot et at, 
1985). 
Pyrimethamine is active against the developing mosquito stages of the parasite (Black et 
ai, 1986; Desjardins et ai, 1988) but it does not prevent the development of oocysts in 
isolates of P. falciparum that are resistant to the drug (Teklehaimanot et ai, 1985). 
Pyrimethamine and other parasite-specific inhibitors of dihydrofolate reductase and 
sulfonamides interfere with DNA synthesis by the parasite during sporogonic development 
in the mosquito (Carter & Graves , 1988). 
1 .3.2 Vector Control 
Personal protection against and prevention of mosquito bites are important especially during 
the rainy season when mosquitoes are in abundance, due to the availability of more 
hreeding places (Baker et ai, 1993). Visits to endemic areas should he undertaken during 
the dry season or when rainfall is low. A voiding malarious areas altogether is 
recommended for hahies and children under five years, pregnant women, the elderly (above 
65 years) and for immunocompromised individuals (Baker et at, 1993; Frean & Blumberg, 
1993). 
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Mosquito attacks can also be avoided by not going out of doors between dusk and dawn 
as mosquitoes are most active at this time. Wearing long sleeves and long trousers at night 
can also help to prevent mosquito mouthparts from penetrating the skin (Dep. Nat. Health 
Pop. Dev. , 1993). Protection against mosquitoes includes the use of bednets impregnated 
with an insecticide, the screening of windows and doors and the use of mosquito coils or 
the intradomiciliary spraying with knockdown insecticides of the resting places of 
mosquitoes (Frean & Blumberg, 1993; Wernsdorfer, 1986). One of the oldest insecticides 
is DDT which has been in use for more than 30 years, although there are some fears that 
the mosquitoes might be developing resistance to this chemical (Hansford, 1993; K waZulu 
Dep. Health, 1991). Use of DDT is no longer being encouraged in South Africa since the 
components are environmentally unfriendly (Dr B.L. Sharp, pers. comm., 1994). Ficam 
and deltamethrin are other insecticides effective against the mosquitoes. Deltamethrin is 
cheap and recent studies (Dr B.L. Sharp, pers . comm. , 1994) carried out in northern 
KwaZulu-Natal showed that this insecticide produced 100% mortality when applied for 
several weeks in mosquito-infested houses. 
Lambda-cyhalothrin (ICON) is very effective not only against mosquitoes but it also 
controls bedbugs within the endemic malaria area. This pyrethroid is well-tolerated and 
non-staining and it can be applied on furniture as well. (Ie Sueur et ai, 1993; Sharp et ai, 
1993) . Repellents which contain di-ethyl toluamide are most effective but they have a short 
active life (Frean & Blumberg, 1993). Larvicides such as temephos can be applied to water 
to control the immature stages of mosquitoes. Malaria oil which is cheaper than other 
larvicides can be used effectively as well (KwaZulu Dept. Health , 1991). 
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1.4 SOUTHERN AFRICAN REFERENCE ISOLATES OF P. FALCIPARUM 
The isolates of P. falciparum used in this study were obtained from malaria patients and 
maintained in culture before cryopreservation for future use (Freese el ai, 1991). The 
isolates RSA 2, 3, 5, 6, 9 and 14 were collected from the former KwaZulu on 28/1/85 , 
11/3/85, 12/3/85, 10/7/84, 2/9/86 and 4/2/87 respectively and MW2 was isolated on 
22/7/86 from a patient who imported malaria from Malawi. These reference isolates have 
been characterized previously according to their isoenzyme types (Freese & Markus, 1990), 
antigen variants (Freese et ai, 1990) and drug sensitivity (Freese et ai, 1991; Freese, 
1994). Little variation among these isolates was revealed by the isoenzyme-typing 
technique (Freese & Markus, 1990), and the antigenic composition of most of them showed 
marked ditlerences compared to those obtained in other areas (Freese et ai, 1990). The 
responses of these reference isolates to chloroquine were as follows: RSA 2, 3, 5 were 
sensitive to the drug and RSA 6, 9, 14 and MW2 were found to be resistant (Freese el ai, 
1991). 
1.5 OBJECTIVES 
The objectives of this study are: 
1. To produce gametocytes in vitro from reference isolates using different methods of 
stimulation. 
2. To compare gametocyte production rates and extlagellation in these isolates. 
3. To examine the effect of pyrimethamine on gametocytogenesis, extlagellation and 
asexual growth of P. falciparum. 
18 
4. To investigate the action of chloroquine alone, and in combination with pyrimethamine, 
on asexual stages of P. faiciparum. 
The study was conducted with the hope that the results will help in future malaria research 
in southern Africa. If mature gametocytes can be maintained under laboratory conditions 
for long enough, this would enable further studies involving the investigation of current 
and new drugs aimed at the sexual stages of the parasite and studies involving the 





Gametocytes are formed during the erythrocytic phase of the malaria parasite, P. 
jalciparum, in the human host (Olsen, 1974). For the parasite to complete its life cycle, 
a second host, the mosquito is required. It is in this second host called the vector, that the 
gametocytes undergo further development by producing gametes which, upon fertilization 
of the macrogametes by microgametes, develop into a zygote. Following a series of 
divisions and developmental stages oocysts are formed which produce transmission stages, 
the sporozoites. 
Earlier experiments had enabled production of gametocytes in vitro. From the observations 
of other workers it is possible to perform experiments on P. jalciparum parasites and study 
their life cycle, especially the blood stages. Trager & Jensen (1976) developed techniques 
for culturing the blood stages of P. jalciparum in vitro. Their methods were later modified 
by other investigators to optimise gametocyte production. According to Vanderberg (1988), 
gametocytogenesis in vitro involves two processes, the induction process which results in 
the formation of gametocytes from asexual parasites and the development of these 
gametocytes into mature and infective parasites. 
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2.2 CULTURE TECHNIQUES 
Various techniques have been developed for culturing P. jalciparum asexual hlood stages. 
Jensen (1988) classified these techniques into two, that of short-term cultivation of human 
and numerous animal species of malaria , and that of the continuous cultivation of P. 
jalciparum. Rocker-dilution procedures were used for short-term cultures, but these were 
found to be useless for P. jalciparum which spends most of its 48-hour growth cycle of 
erythrocytic schizogony attached to the endothelium of the capillaries (Jensen, 1988). 
RPMI 1640 culture medium replaced the standard 'Harvard medium' which was used 
with a custom built flow-vial method. This method became outdated after the RPM I 1640 
medium was developed (Jensen, 1988). The common method suitable for continuous 
culture is the petri dish candle jar method (Jensen & Trager, 1977). Here the complete 
medium (discussed later in this chapter) is used to dilute a suspension of infected and 
uninfected red blood cells to make a 12% erythrocyte suspension. Aliquots (1.5mf) of this 
suspension are then dispensed into 35mm plastic petri dishes. The dishes are placed in a 
glass desiccator with a candle. The candle is lit and the cover put on with the stopcock 
open. When the candle tlame goes out the stopcock is closed and the jar is set at 37°C. 
However, observations involving maintaining P. falciparum in continuous culture showed 
that the petri dish candle jar method was not suitable for growing southern African isolates 
(Freese et ai, 1988a). The method developed hy Jensen (1981) also for maintaining 
continuous cultures of P. falciparum is said to be very simple and requires no peristaltic 
pumps or special filters to change the medium. This technique requires a daily maintenance 
of about 30 minutes. 
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Several variations of this system have been developed using tissue culture flasks of 
different volumes in place of glass vessels. A semi-automated cultivation apparatus for 
the in vitro culture of P. faiciparum has been described by Ponnudurai et ai (1982b). This 
method enables the change of the culture medium at preset intervals, but it is very 
expensive in design and construction. It can be used for synchronization of parasites 
(Ponnudurai et ai, 1986). In all the culture techniques used , the important ingredient is the 
mixture of gases used in the range 2-5% carbon dioxide, 3-8% oxygen and the balance 
heing nitrogen (Jensen, 1988) . 
2.3 PRODUCTION OF GAMETOCYTES 
2.3.1 Isolates 
The choice of a suitable isolate is of utmost importance because some isolates are known 
to have never produced gametocytes (Bhasin & Trager, 1984). According to Ponnudurai 
et ai (1986) a good isolate should be sensitive to chloroquine, produce a reasonable number 
of gametocytes over a relatively long period and have asexual parasites which multiply 
relatively slowly allowing the sexual stages to mature over a two-week period. This is true 
of our southern African chloroquine-sensitive isolates of P. faiciparum maintained in the 
Durban lahoratory of the Medical Research Council, namely, RSA 2, RSA 3 and RSA 5 
(Freese et ai, 1988h) . These isolates produce a large number of gametocytes when 
stimulated in vitro. Some studies have suggested NF54, NF7 and NF36, Tanzanian isolates 
IICDC, Honduras I/CDC and Brazilian ltuxi 084 and IMTM22 to he good isolates 
(Vanderberg, 1988). 
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Graves et at, (1984) performed experiments comparing the rates of gametocyte production 
by five isolates of P. faiciparum: two Brazilian and three African. They (Graves et ai, 
1984) showed that the isolates differed in their intrinsic rates of gametocyte production. 
ltuxi 084 was found to be signiticantly different from the other four isolates. 
2.3.2 Culture medium 
The widely used RPMI 1640 medium is supplied in two forms, liquid and powder (Jensen, 
1988) and medium is prepared by using the method described by Jensen & Trager (1977). 
Briefly, the medium is dissolved in redistilled water and to it is added 5. 95g N-2-hydroxy-
ethylpiperazine-N-2-ethane-sulfonic acid commonly known as HEPES to give a final 
concentration of 25 mM with a pH of 6.75. The solution is diluted to 960mf and sterilized 
through a 0.22/Lm millipore filter. It is dispensed aseptically in 96mf amounts and stored 
at 4°e. For use 96mf medium is supplemented with 4.2mf of 5 % NaHC03 solution to give 
a medium without serum known as the incomplete medium. 
2.3.3 Serum 
To make the complete medium, 10% human serum is added to the incomplete medium 
(Jensen & Trager, 1977). The most widely used serum is type AB-positive or type A-
positive serum (Carter & Miller, 1979; Jensen, 1988). Freese et ai (l988a) used human 
type A-positive serum for routine cultures and AB-positive serum in newly initiated 
cultures to avoid damaging the infected cells of the patient. The serum is stored at -20°e. 
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2.3.4 Red blood cells 
For P. /alciparum cultures, the readily availahle O-positive and A-positive erythrocytes are 
used. Human a-positive .cells are collected in lithium-heparin and stored as whole blood 
at 4°C for up to a week after collection (Freese et al, 1988a). Before use the blood is 
washed twice in incomplete medium. 
2.3.5 Cultivation procedure 
Mature gametocytes can he produced hy using the static method described by Ponnudurai 
et al (1982b) or by the synchronization method described by Ponnudurai et al (1986). In 
the static method the parasites are cultured in tissue-culture flasks containing about 5 % 
suspension of infected cells. Normal red blood cells and the culture medium are added. 
The flasks are gassed with 4% CO2, 3% O2 and 93% N2• The lids of the flasks are tightly 
closed. The culture tlasks are incubated at 38°C. When gametocytogenesis has heen 
stimulated, the red blood cells are not replenished and during each daily medium change 
the flasks are handled with care to avoid disturbing the cells. Care is taken to ensure that 
the cultures are not exposed to low temperatures. 
The stages of maturity of gametocytes are observed daily for three weeks. Gametocyte 
counts are made per 10 000 red hlood cells. When using the synchronization method the 
cultures are harvested on day four after normal daily medium change. A 10% suspension 
of the cells is mixed with an equal amount of sterile 2 % (w\v) gelatin (300 hloom). The 
mixture of gelatin-cells is allowed to stand for 30 minutes in a waterbath at 37°C. The 
supernatant fraction of the mixture containing schizont-trophozoite mixture is washed twice 
hy centrifugation in culture medium. 
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Washed, fresh cells are added to the pellet to reduce the parasitaemia which is then 
suspended in complete medium to 5 % and placed in a tissue culture flask which is gassed 
and incubated at 38°C. N-Acetyl glucosamine at a final concentration of 50mM is added 
12 hours later. The medium containing the above concentration replaces the normal 
medium for the next 72 hours. Four to five hours after N-acetyl glucosamine is added a 
blood smear is made. 
2.4 INFECTIVITY TO MOSQUITOES 
Infectivity of cultured gametocytes of P. Jaiciparum to mosquitoes depends on the choice 
of appropriate isolate with facilities for cryopreservation, good techniques for initiation of 
cultures, and the quality of serum used for culture and inclusion in the feed material for 
mosquitoes (Ponnudurai et ai, 1989b). The species of the mosquito also plays an important 
role in infectivity (Klein et ai, 1991a). When infecting mosquitoes, the culture medium 
containing mature gametocytes is fed to mosquitoes through membrane feeders usually 
under a water-jacket at 37°C for about 10 minutes (Burkot et ai, 1984; Dearsly et ai, 1991; 
Ponnudurai et ai, 1982a). After the blood meal, the mosquitoes are maintained at 28°C on 
sugar water (Burkot el ai, 1984) or a diet of raisins (Smalley & Sinden, 1977) . After a few 
days the numbers of oocysts and sporozoites are counted in one of the following ways: 
1. dissect the mosquitoes, tix in 10% formalin, dehydrate in 70% ethanol, stain in 
haematoxylin and examine their guts (Beier el ai, 1991: Dearsly el ai, 1991; Smalley & 
Sinden, 1977; Vermeulen el ai, 1983) . 
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2. use of monoclonal antibodies specific for the circumsporozoite (CS) protein by enzyme-
linked immunosorbent assay (ELISA) (Klein et ai, 1991a), immuno-radiometric assay 
(IRMA); these are known to detect as few as 100 sporozoites per mosquito, nitrocellulose 
(NC) membrane and immunofluorescence antibody assay (I FAA) which can be used to 
identify the species of mosquito involved in rodent and human malaria (Delves et ai, 1989; 
Petros et ai, 1989). 
2.5 EFFECT OF SPORONTOCIDAL DRUGS ON INFECTIVITY 
Young gametocytes are destroyed by all blood schizontocidal drugs. Mature gametocytes 
are sensitive to 8-aminoquinolines such as pamaquine and primaquine (Carter & Graves, 
1988). The action of these drugs is restricted to gametocytes circulating in the blood and 
they do not affect gametogenesis, fertilization or sporogonic development. In some case 
studies, gametocytes from malaria patients have been shown to infect mosquitoes 20 days 
after treatment with chloroquine, quinine and quinine plus tetracycline (Klein et ai, 1991b). 
When patients were treated with primaquine, they did not demonstrate gametocytes or had 
abnormal gametocytes in their blood 24 hours after treatment and these gametocytes were 
not infective to mosquitoes (Klein et ai, 1991b). However, not all antimalarials have 
sporontocidal properties. Chloroquine does not demonstrate sporontocidal or 
gametocytocidal activity on mature gametocytes (Herbst, et at, 1985) because chloroquine 
and other 4-aminoquinolines interfere with digestion of haemoglobin by the malaria 
parasites whether asexual or gametocyte. Once the parasites have passed the stage of 
Jigestion of haemoglobin at about six days of age , gametocytes of P. falciparum are no 
longer affected by chloroquine (Carter & Graves, 1988; Smalley & Sinden, 1977). 
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In South Africa pyrimethamine was used in combination with chloroquine for both 
prophylaxis and treatment of malaria until recently , presumably for its sporontocidal effect. 
Pyrimethamine and other parasite-specific inhibitors of dihydrofolate reductase and 
sulfonamides both interfere with the formation of precursors of DNA synthesis by the 
parasite when it recommences during sporogonic phase in the mosquito (Carter & Graves, 
1988). When DNA synthesis has stopped and drug administration is discontinued, the 
gametocytes reach maturity and they regain their infectivity to mosquitoes. 
The sporontocidal activity of pyrimethamine was confIrmed by Teklehaimanot et ai (1985). 
They found that pyrimethamine had a sporontocidal effect on the strains of P. Jaiciparum 
that were sensitive to the drug but not on the resistant ones. Freese et ai (1991) found that 
the asexual blood stages of the majority of southern African isolates tested had a reduced 
susceptibility to pyrimethamine in vitro. However, it is not known whether these culture-
adapted isolates are resistant to the sporontocidal effect of pyrimethamine. Since the 
effIcacy of pyrimethamine on its own has decreased dramatically, alternative drugs with 
tolerable side effects need to be investigated. 
Chloroquine resistant P. faiciparum has been reported in eastern Asia and South America 
(Wernsdorfer, 1991). Resistance to the sulfadoxine/pyrimethamine combination has been 
reported in some areas (Wernsdorfer, 1986; Watt et ai, 1987). The question of drug 
resistance in P . .!aiciparum is a problem not only to southern Africa (Freese et ai, 1988b; 
1991; Herbst et ai, 1987) and other parts of Africa (Brasseur el ai, 1987; Desjardins et ai 
1988; Freese, et ai, 1988b; Hellgren et ai, 1987), but to the whole world (Wernsdorfer. 
1991). 
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The responses of P. JaLciparum isolates to sporontocidal drugs other than pyrimethamine 
need further investigation and the effects of these drugs on the gametocyte infectivity to 





Gametocytogenesis involves two important processes, the first is the development of the 
asexual stages and the second, maturity of the gametocytes. There are three main factors 
that intluence the production of gametocytes of P. faiciparum in culture; 1) the type of 
isolate used, 2) the duration of culture and 3) the conditions under which the culture is 
maintained (Vanderberg, 1988). The objectives of this study were: 
-to stimulate gametocytogenesis by the static and the synchronisation methods, 
-to compare the static and synchronization methods on the basis of gametocytogenesis and 
-to characterize the southern African isolates of P. faiciparum according to their production 
of gametocytes. 
3.2 MATERIALS AND METHODS 
3.2.1 Isolates of Plasmodiumfalciparum 
Four southern African isolates; RSA 2, RSA 3, RSA 5, MW2 and one Amsterdam Airport 
strain (NF54) were used. The four southern African isolates were collected in lithium-
heparin from malaria patients in the KwaZulu-Natal province (Freese et ai, 1991) and 
NF54 (Ponnudurai et al. 1982h) was ohtained from the Department of Immunology and 
Infectious Diseases, John Hopkins University, Baltimore, USA. These isolates were 
removed from cryopreservation and thawed at 37°C. 
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The infected cells were immediately washed successively in 12 % sodium chloride (0.2 
mell me cells) , 1.6% sodium chloride (9 volumes) and 0.9% sodium chloride plus 0.2% 
glucose (9 volumes) before being cultured (Freese et ai, 1988a). 
3.2.2 Uninfected red blood cells 
Human O-positive cells obtained from various donors working in the Malaria Laboratory 
of the South African Medical Research Council (Durban), were collected in lithium-heparin 
and stored as whole blood at 4°C. Before use , the cells were washed twice by 
centrifugation in incomplete culture medium (see Chapter 2) . Care was taken when 
removing the buffy coat (Freese et ai, 1988a). 
3.2.3 Serum 
Human A-positive serum obtained from "the Border Blood Transfusion Services" , East 
London, was used in all the cultures. The serum was stored at -200t. 
3.2.4 Culture medium 
The RPMI 1640 medium (Flow laboratories. Irvine, Scotland) buffered with HEPES was 
prepared following the method described by Jensen & Trager (1977) (see Chapter 2) and 
supplemented with glucose (4g/f), hypoxanthine (44mg/f) , gentamicin (50mg/f) and 10% 
human serum (Freese et ai, 1988a; 1991) . 
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3.2.5 Cultivation procedure 
All the above ingredients were warmed to 37°C before culturing. The cultures were 
initiated in 50mf tissue-culture flasks containing 5m£ of a 5 % suspension of infected cells 
in the culture medium. The Basks were gassed with a mixture of 3% O2 , 4% CO2 , and 
93 % N2 for lO seconds (Fig. 3) and the lids were tightly closed. The flasks were then 
incubated at 38°C on a shaker platform. The shaker was switched off two hours before each 
daily medium change to allow the erythrocytes to settle. The tlasks were gently tilted to 
allow spent medium to be aspirated off. Fresh, warm medium was added to the flasks 
which were then gassed before incubating them. The cultures were diluted with fresh 
erythrocytes every three to four days. Parasite growth was assessed by examining Giemsa 
stained smears prepared from settled cells. Parasite counts (Fig.4) were made daily per 10 
000 red blood cells under X 1000 oil immersion microscopy. When the parasitaemia 
reached about 5 %, the cultures were transferred to 250mf tissue-culture flasks (15m£ 
medium, 5 % haematocrit) and maintained as before. 
3 .2.5. 1 Static cultures 
Gametocytogenesis was stimulated In static culture flasks when the parasitaemia had 
reached 5 % or more. The cultures were initiated at 5 % haematocrit and the infected cells 
were diluted with a-positive red blood cells to 0.3-0.5% parasitaemia. No erythrocytes 
were added to these cultures once the experiment was set up. The medium was changed 
uaily, care being taken not to disturb the settled layer of cells and exposure to lower 
temperatures kept to minimum. The tlasks were maintained for up to 21 days. 
Gametocytaemia was determined daily per 10 000 red blood cells counted from Giemsa-
stained smears. 
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Fig. 3. Culture system, tissue-culture tlasks heing gassed with a mixture of 3 % 02, 4 % 
CO2 and 93% N2 -
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3.2.5.2 Synchronized cultures 
In some cultures gametocytogenesis was stimulated by the synchronization technique as 
described by Ponnudurai et al. (1986). Brietly when the cultures had reached 5-10 % they 
were harvested and a 10% suspension of cells was mixed in a 15mf test tube with an equal 
amount of sterile 2 % gelatin (300 bloom) in incomplete medium. 
This mixture was left for 30 minutes in a water bath at 37°C to allow the blood stages to 
separate. The supernatant fraction of the mixture which contained mainly schizonts, was 
washed twice in culture medium by centrifugation. Fresh, washed and warm red blood 
cells were added to the pellet to reduce the parasitaemia to 5 % and increase the haematocrit 
to 5 %. The cultures were put back into the culture flasks and incubated at 38°C after 
gassing with a mixture of 3% CO2, 4% O2 and 93% N2 • 
Twelve hours later, N-acetyl glucosamine (NAG) at a final concentration of 50mmollf, 
was added to the cultures to eliminate the trophozoite and the schizont stages, leaving the 
ring stages intact. This NAG-containing medium at the above concentration replaced the 
normal medium for the next three days. A smear was prepared four to tive hours after the 
initial addition of NAG. These cultures were maintained for 21 days and daily gametocyte 
growth was monitored by examining Giemsa-stained smears. For statistical analysis of the 
results refer to Chapter 5 section 5.2.1. 
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3.3 RESULTS 
Figures 5-9 show the numbers of asexual parasites and gametocytes (all stages)/1O ()()() red 
blood cells produced in static cultures by RSA 2, 3, 5, MW2 and NF54 respectively. 
Isolate RSA 2 was maintained in culture for 11 days , isolates RSA 3, 5 and NF54 were 
cultured for 21 days and MW2 for 10 days. Isolate RSA 2 reached peak gametocytaemia 
of 1 % on day ten (Fig. 5) , while three isolates, RSA 3, 5 and NF54, attained their highest 
number of gametocytes (5.8%, 4.5% and l.8% respectively) after eight days. Isolate MW2 
was the only exception with peak gametocytaemia of 1.25 % within two days. AU the 
isolates showed a similar pattern: gametocytaemia increased with a decrease in the asexual 
stages and vice versa (Figs. 5-9). 
Figures 10-14 compare the numbers of gametocytes produced/ 1 0 ()()() RBCs in static and 
synchronized cultures by NF54, RSA 2, 3, 5 and MW2 respectively. A peak 
gametocytaemia of 11 % was obtained in the synchronized cultures of isolate NF54 (Fig. 
10). Figure 11 shows the highest number of gametocytes on day one for synchronized 
cultures than in the static for isolate RSA 2. The remaining three isolates (RSA 3, 5 and 
M W2) produced high gametocytaemia (of 3. 1 %, 6.8 % and 2.4 %) on days 19, eight and 
two respectively (Figs. 12, 13 and 14). The two methods of gametocyte stimulation, the 
synchronization and the static, compared as follows : 
For RSA 2 and RSA 5 (Figs 11, 13), there were no statistically significant differences 
between the two methods (Appendix 1). For RSA 3, more gametocytes were produced in 
the static than in the synchronized cultures (Fig. 12) and there was a statistically significant 
difference between the two methods at p-value of < 0 .0 l. (Appendix I). 
FIG.5. Parasite counts of isolate RSA2 
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FIG.9. Parasite counts of isolate NF54 
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Fig. 15. The asexual blood ring stage. The micrograph was taken from in vitro 
static cultures of P. Jalciparum isolate RSA 2 (Xl000 magnification). 
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Fig.16. Gametocyte stage II (on the left) and stage III (on the right). The 
micrograph was taken from in vitro static cultures of P. Jalciparum isolate RSA 2 
(XlOOO magnification). 
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Fig. 17. Gametocyte stage IV (see Chapter 1 for description). The micrograph was 
taken from in vitro static cultures of P. Jalciparum isolate RSA 2 (Xl000 
magnification) . 
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Fig. 18. Mature stage V gametocyte. The micrograph was taken from in vitro static 
cultures of P. Jalciparum isolate RSA 2 (XlOOO magnification). 
44 
Higher numbers gametocytes were obtained in the synchronized than the static cultures of 
isolates NF54 and MW2 (Figs. 10 and 14 respectively). Appendix 1 shows that there were 
statistically significant differences between the two methods of gametocyte stimulation for 
both MW2 and NF54 (p<0.05 each). Figures 15-18 show the stages of the gametocyte 
development of P. faiciparum (as described in Chapter 1, section 1. 2.1) taken from the 
static cultures of the isolate RSA 2. The Stage I gametocyte is not shown because there is 
no clear distinction between the Stage I and the trophozoite morphologies. 
3.4 DISCUSSION 
Most isolates attain their peaks after eight days . The only exception was MW2 which 
reached a peak of 1.25% within two days . All the gametocyte stages (Figs. 15-18) were 
observed for both methods of stimulation. For the isolates RSA 2, RSA 3 and RSA 5 the 
gametocytes reached maturity within seven days of stimulation (Ponnudurai et ai, 1986). 
This means that their ability to produce gametocytes is not reduced like MW2 whose 
gametocytes did not reach maturity within 21 days. 
The fact that gametocytes were produced from isolate MW2 at all indicates that this isolate 
can still be stimulated to produce. However, it appears that something in the culture system 
is preventing these gametocytes from maturing. This appears to be the same for the 
Amsterdam airport strain, NF54, which formed mature Stage V gametocytes on day 12 in 
the synchronized cultures only and these were in very, very low numbers, i.e. 0.01 %. The 
Stage V gametocytes in this isolate did not last long, disappearing after two days, and no 
mature gametocytes could be detected afterwards. 
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This isolate is maintained in several laboratories around the world and is known to be a 
good gametocyte producer (Ponnudurai et aI, 1982a). However, it seems that local 
gametocyte culture conditions need to be optimised for this strain. The asexual stages of 
this isolate, however, became adapted to local culture conditions after being cultured for 
four weeks. 
3.5 CONCLUSION 
Of the 19 southern African reference isolates of P. jaiciparum, the three chloroquine-
sensitive strains (RSA 2, RSA 3 and RSA 5) have been shown to be good producers of 
gametocytes when stimulated under appropriate laboratory conditions. Although MW2 and 
NF54 do produce gametocytes, they do so at a much slower rate. Emphasis should be 
based on the culture system ingredients (serum, RBCs and culture medium) to try and 
establish the requirements for these isolates. 
For RSA 2, 3 and 5, it does not really matter what method of gametocyte stimulation is 
used since no significant differences were found between them (Appendix 1). Isolates , 
MW2 and NF54 responded readily to the synchronized method. The extent to which 
individual isolates produce gametocytes may be subject to some degree of environmental 
changes. Cloned lines of the isolates (though not investigated in this case) may playa vital 
role in their variation in gametocyte production (Graves & Carter, 1988). Gametocytes 
produced from routine cultures can be used to carry out studies involving many aspects of 
malariology such as drug tests and infectivity to mosquitoes. 
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Large numbers of gametocytes are required to develop our field of study further especially 
the biochemical, the epidemiological and the physiological studies since not much research 
involving gametocytes has been done. Gametocytes are the transmission stages from man 
to mosquito. Knowing more about these infective stages of the parasite, will help in the 





The successful maturation of gametocytes leads to the production of gametes. For this to 
occur the gametocytes must fIrst be ingested by mosquitoes or demonstrated under in vitro 
conditions. During the gamete formation process, known as exflagellation, the male 
gametocyte forms exflagellated microgametes or the male gameteS'. Under in vitro 
conditions, exflagellation needs a lower temperature and higher pH than those for 
gametocyte development. Exflagellation may be observed in the presence of fetal bovine 
serum (FBS) adjusted to pH 8.0 with 1.5% NaHC03 at 26°C (Carter & Beach, 1977). 
Unlike gametocytes which take hours to develop, gametes are reported to be produced 
within 10-20 minutes of stimulation (Carter & Beach, 1977). The purpose of this part of 
the study was to investigate whether exflagellation could be stimulated under in vitro 
conditions from laboratory-produced gametocytes. 
4.2 MATERIALS AND METHODS 
4.2.1 Experimental procedure 
Exflagellation was stimulated by the method described by Carter & Beach (1977) in static 
cultures of those isolates which produced mature Stage V gametocytes (RSA 2, 3 and 5) 
and in synchronized cultures of RSA 2 and 5. Exflagellation was not stimulated in MW2 
and NF54 cultures or in the synchronized cultures of RSA 3. 
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These isolates produced young gametocytes which lasted up to day seven only and 
thereafter these immature gametocytes either became morphologically abnormal or 
disappeared. When the gametocytes had reached maturity, the cells were evenly 
resuspended in their own culture medium and O.3mf of the suspension was dispensed in 
a serum tube containing 3.0mf Foetal Bovine Serum (FBS) adjusted to pH 8.0 with 
NaHC03 • The cells were then sedimented by centrifugation for 30 seconds. Most of the 
supernatant was removed leaving only a minimal amount to mix with the sediment. One 
drop of this cell-FBS mixture was placed on a slide covered with a coverslip and stored 
in a humid chamber at 26°C. 
The preparation was observed under a phase-contrast microscope at X400 magnification 
(Carter & Beach, 1977; Dearsly et ai, 1990; Sinden et ai, 1984; Vermeulen et ai, 1983) 
at 15 minutes intervals for 60 minutes. The numbers of exflagellating parasites were 
counted in 40 microscopic fields. In other experiments, the FBS was not used and 
gametocytes were suspended in the culture medium containing 10% human serum. This 
was initiated in two samples of isolate RSA 5 cultures. Exflagellation was assessed by 
counting the total number of exflagellations after 60 minutes in 30 microscopic fields. 
4.2.2 Statistical analysis 
A two-way Analysis of Variance was used to compare the isolates, RSA 2 and RSA 5. The 
two classification variables were ISOLATE and TIME. To avoid confusion the analysis is 
not shown here only the p-values are mentioned in the results section. 
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4.3 RESULTS 
Exflagellation was observed in the static cultures of all the three isolates i.e. RSA 2, 3 and 
5 (Table 1). In the synchronized cultures (Table 2), RSA 2 produced more exflagellations 
within 60 minutes than RSA 5. The difference was statistically significant at p < 0.0120. 
However, the difference between the total number of exflagellations produced within 60 
minutes in the static and synchronized cultures of each of RSA 2 and 5 respectively was 
not statistically significant. 
The number of exflagellating parasites increased with an increase in observation time 
(Tables 1-2). Table 3 shows the total number of exflagellations counted after 60 minutes 
in both the static d the synchronized cultures of RSA 5. More exflagellations were 
obtained in sample 2 (67 for static and 204 for synchronized) than in sample 1 (55 for 
static and 99 for synchronized). Furthermore, more exflagellations were produced in the 
synchronized (99 and 204) than in the static (55 and 67) cultures of both samples (Table 
3). 
Because of the small sample size, the results obtained in the presence of FBS were not 
compared to those obtained when FBS was not added to the cultures. However, the total 
number of exflagellations obtained in the presence of FBS in static cultures was 60 
compared to 55 and 67 obtained in the samples respectively (Tables 1 and 3). Higher total 
numbers of exflagellations were produced in the synchronized cultures without FBS than 
in the same cultures containing FBS (Tables 2 and 3). 
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Table 1. Number of exflageUations in 40 microscopic fields obtained in the presence 
of FBS in static cultures. 


























Table 2. Number of exflagellations in 40 microscopic fields obtained in the presence 
of FBS in synchronized cultures. 




















Table 3. The total number of exflagellations obtained in the absence of FBS after 












Under laboratory conditions, exflagellation was demonstrated in RSA 2, 3 and 5 isolates. 
These three isolates produced mature gametocytes. These three isolates are also known to 
be chloroquine-sensitive (Freese et al, 1991). This indicates that all the three chloroquine-
sensitive southern African isolates which originally came from the KwaZulu-Natal province 
can readily produce gametocytes which will under go exflagellation when stimulated. These 
results are consistent with those of Carter & Beach (1977) in that after 10 minutes 
exflagellation was observed. Furthermore, gametogenesis was observed both in the 
preparations containing FBS and human serum respectively. 
The methods of gamete stimulation produced the same results for the same isolate (e.g. 
RSA 2 had 85 exflagellations per 40 microscopic fields after 60 minutes in the static 
system and 84 in the synchronized cultures), but there were marked differences in the total 
number of exflagellations within the synchronized culture system between RSA 2 and RSA 
5 (84 total number of exflagellations produced after 60 minutes for RSA 2 and 64 for RSA 
5) (Table 2). Although the two samples obtained from isolate RSA 5 were not statistically 
analyzed, more exflagellations were observed in sample 2 than in sample 1, and the 
synchronized cultures of both samples produced larger numbers of exflagellations than 
static cultures. Although the effect of FBS on gametogenesis was not statistically significant 
compared to that of human serum, Carter & Beach (1977) found no differences in the 
number of microgametes produced in either FBS or human serum. In contrast, Ponnudurai 
et al (1982a) discovered that more exflagellations were produced in the presence of FBS 
than in the cultures containing human serum. 
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4.5 COMMENTS 
The next step following on from the experiments described in this Chapter, would be to 
try to infect mosquitoes with mature gametocytes in the laboratory. This would give an 
idea of how viable the gametocytes are, since it was observed (Vanderberg, 1988) that in 
some isolates of P. Jalciparum exflagellation never occurred but the gametocytes 
nevertheless produced heavy infections in mosquitoes. In other isolates where 
exflagellations were observed, the gametocytes did not become infective. Production of 
gametes in vitro can be regarded as an indication of successful gametocytogenesis, though 
not all gametocyte-producing isolates will readily undergo exflagellation. It would be 
interesting to investigate further the development of gametes in vitro. The remaining 
southern African isolates of P. Jalciparum should be stimulated to produce gametocytes and 
undergo exflagellation in vitro. Initiation of microgametogenesis using different sera 






Pyrimethamine was formulated with the primary aim of destroying all the asexual blood 
stages of the malaria parasite (Desjardins et at, 1988). This drug is not effective against 
sporozoites or mature gametocytes, but is effective against the young gametocytes of P. 
Jatciparum. It is also active against gametocytes of P. ovaie, p. vivax and P. malariae. 
Pyrimethamine is also known to be effective against the primary exo-erytbrocytic stages 
of all forms of malaria (Black et at, 1986; Desjardins et ai, 1988). Pyrimethamine is 
effective as a drug because it interferes with the parasite's enzyme dihydrofolate reductase 
which is responsible for DNA synthesis, while it does not affect the same enzyme in the 
host (Carter & Graves, 1988; McCutchan, 1988). 
It does however inhibit the enzyme histamine N-methyl transferase, which is responsible 
for the metabolism of histamine in mammalian tissues (Desjardins et ai, 1988; Kemp et ai, 
1990). Like other antifolates, frequent administration of pyrimethamine over a long time 
may cause folate deficiency. It has been reported (Desjardins et ai, 1988; Wernsdorfer, 
1986; WHO, 1982) that a daily dose of 25mg taken weekly caused mild to moderate 
megaloblastic anaemia. Higher doses of this drug can cause side effects such as 
agranulocytosis. Pyrimethamine is an effective sporontocide but it has no effect on mature 
gametocytes or latent tissue stages (Black et ai, 1986). The aim of this study was to 
investigate the effect of pyrimethamine on gametocytogenesis and exflagellation in vitro. 
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5.2 MATERIALS AND METHODS 
The effect of pyrimethamine on gametocytes (all stages) was investigated in the established 
isolates of P. Jaiciparum that had produced gametocytes i.e. RSA 2,3,5, MW2 and NF54 
(Chapter 3) and undergone exflagellation viz. RSA 2 and RSA 5 (Chapter 4). For 
pyrimethamine-treated cultures, exflagellation was demonstrated on RSA 2 and 5 since 
MW2 and NF54 isolates produced only immature gametocytes in their cultures. The 
experiments were run in parallel to those set up in Chapters 3 and 4. For each reference 
isolate two tissue-culture flasks were prepared, one to serve as a control and the other for 
the drug test. 
This can be termed a seven-day drug test because a known concentration of the drug was 
added to the flask each day for seven days, during stimulation of gametocytes. For RSA 
2, MW2 and NF54, a culture medium containing 100nmolli pyrimethamine (Wellcome 
(PTY) LTD) solution prepared in 0.05% lactic acid was added during each daily mediuJIl 
change for seven days. For RSA 3 and 5, 3000nmoll £ of the drug was added. These 
concentrations were based on the isolates' reported minimum inhibitory concentrations 
(MICs) (Freese et ai, 1991) which are defmed as the lowest drug concentration at which 
no parasite growth occurred. The tissue culture flasks were gassed as normal and incubated 
in a static position at 38°C. The effect of pyrimethamine on the morphology of the different 
stages of gametocytes and the number of gametocytes was determined by examining 
Giemsa-stained smears. Parasite counts (all stages of gametocytes were counted) were made 
/10000 red blood cells. When the gametocytes had reached maturity, in both the controls 
and the experiments, exflagellation was stimulated as described in Chapter 4. 
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5.2.1. Statistical analysis 
5.2.1.1 Production of Gametocytes 
All the different stages of gametocytes were counted. the data were first fitted to assess 
trends. It was clear from the trends in the data that polynomial regression had to be 
preformed. Different models were then fitted to the data, e.g. quadratic and cubic 
regression, using actual as well as log counts. The model with the best R2 value, i.e. the 
best fitting model, was then used to describe the trend. In this case, cubic regression 
provided the best fit to the data. The model is described below:-
Production of gametocytes was assessed on different days using 4 different treatments, for 
5 different isolates. 
The treatments were: 
a) Static treatment 
b) Static control 
c) Synchronized treatment 
d) Synchronized control 
The following analyses were done for each isolate separately: 
1. Number of gametocytes/lO 000 RBCs was plotted against time (in days) for the 4 
treatments. 
2. A cubic regression model on the log of the count, which proved to be the best fitting 
model, was fitted to each of the 4 curves. The R2 value was calculated for each model to 
indicate how well it fitted the data. 
3. From the cubic regression analysis, predicted values and standard errors were 
calculated. 
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The least significant difference (LSD) at the 5% level was calculated for the day that 
showed the greatest difference between treatments. The LSD was calculated for : 
- Control v control 
- Treatment v treatment 
- Synchronized treatment v control 
- Static treatment v control 
LSD was calculated as follows: 
LSD = to.05 J (SEI2 + SEl ) 
where SE = standard error for predicted value. 
4. If the difference between the predicted means for the two treatments is greater than the 
LSD, i.e. (PI - P2) > LSD then the two treatments are significantly different at the 5% 
level of significance (where PI = predicted value for treatment 1 and P2 = predicted value 
for treatment 2). 
5.2.1.2 Exflagellation 
The data that were analyzed did not follow a normal distribution, and linear models could 
not be fitted to the data. Therefore, a class of statistical models that generalizes classical 
linear models by the use of a transformation had to be applied. This is called Generalised 
Linear models, and it includes special cases of analysis of variance models, logit and 
probit models for quantal responses and multinomial response models for counts. In the 
case of these data, the model that provided the best fit to the data was the Poisson 
regression. The Generalised Linear Models procedure was used to analyze the data. A 
Poisson regression was fitted to the number of exfiagellations counted in 40 microscopic 
fields every 15 minutes. 
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For each isolate a comparison was made over time, synchronized was compared to static, 
treated was compared to control, and interactions were investigated. This analysis was 
carried out on RSA 2 and RSA 5 isolates only because they had undergone exflagellation 
(Chapter 4). 
5.3 RESULTS 
Figures 19-23 show the plots for the log of the number of gametocytes against the period 
(in days) for which the parasites were maintained in culture. Each figure represents an 
isolate of P. JaZciparum and each includes the four comparisons mentioned above. At the 
previously determined minimum inhibitory concentration (MIC) of l00nmol/£ there was 
no significant difference between the gametocyte counts of the control and drug-treatments 
in the static cultures of isolate RSA 2, but for the synchronized cultures there was a 
significant difference (p < 0.05) (Table 4). 
Gametocyte morphology was not affected by pyrimethamine in this isolate but the 
immature stages of gametocytes were affected and this resulted in lower mature gametocyte 
numbers. The cultures of isolate RSA 3 were highly affected by the drug at the MIC of 
3.0jlmol/£ (Fig. 20). The statistical analysis of the results for both the static and the 
synchronized cultures showed that there was a significant difference between the controls 
and the experiments (p < 0.01 and p < 0.001 respectively) (Table 5) with pyrimethamine 
resulting in few gametocytes. Figure 21 shows the plots for the cultures of isolate RSA 5. 
The morphology of the different stages of gametocytes was not affected by the drug but 
their numbers were affected. 
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The statistical analysis of the results for this isolate showed that there was a significant 
difference at p < 0.05 between the static control and the drug-treated cultures and at 
p < 0.01 for the synchronized control and the drug-treated cultures (Table 6) with treatment 
resulting in lower numbers of gametocytes. For isolate MW2 (Fig. 22), the synchronized 
cultures were not affected by the drug, but the static cultures were affected and there was 
a significant difference at 5 % level of significance between the control and the treated 
experiments (Table 7). All the cultures (both static and synchronized) of NF54 (a foreign 
isolate, an Amsterdam Airport strain) , were highly affected by the drug (Fig. 23). 
The statistical analysis of the results showed that there was a significant difference between 
the controls and the experiments (p < 0.01 each) (Table 8). There was ·no significant 
difference between the pyrimethamine-treated static and the pyrimethamine-treated 
synchronized cultures for all the five isolates (Tables 4-8). Appendix 7 shows the peak 
numbers of Stage II gametocytes counted per 10 000 RBCs for the five isolates, RSA 2, 
3, 5 MW2 and NF54. the numbers within the brackets next to the control figures denote 
the days on which the peak values were attained. 
Only Stage II gametocytes were counted to represent the immature stages of gametocytes 
because Stage I gametocytes look similar to the asexual trophozoite stage of the parasite. 
In the static cultures of isolate RSA 2 the number of Stage II gametocytes peaked to 16 
(control) and 22 (pyrimethamine trial) on the eighth day after initiation of cultures. 
Pyrimethamine treatment of the synchronized cultures of isolate RSA 2 and all the cultures 
of other four isolates i.e. RSA 3, 5, MW2 and NF54, resulted in reduced numbers of 
young gametocytes (see Appendix 7). 
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Exflagellation was observed in all the control and pyrimethamine-treated cultures of both 
RSA 2 and RSA 5 respectively (Tables 9 and 10). The statistical analysis of the 
exflagellation experiments is as follows: 
1. Isolate RSA 2: 
There were significantly more exflagellations in the control group than those treated with 
pyrimethamine (p < 0.01), with no statistically significant differences between static and 
synchronized cultures (Fig. 24). The change over time was highly significant (p<O.OOI). 
2. Isolate RSA 5: 
The synchronized treated cultures had significantly more exflagellations than any other 







Fig. 19. Log of the number of gametocytesllO 000 RBCs (LGAM) 
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Fig. 22. Log of the number of gametocytesllO 000 RBCs (LGAM ) 
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Fig. 23. Log of the number of gametocytesllO 000 RBCs (LGAM) 
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Table 4. Statistical analysis of the results shown for isolate RSA 2 in Fig. 19. 
comparison Diff. in Pro value 
ctrl v Ctrl 0.5 
Trt v Trt 1.1 
st. ctrl v Trt 













Table 5. Statistical analysis of the results shown for isolate RSA 3 in Fig. 20. 
Comparison Diff. in Pr. value LSD p-value 
Ctrl v Ctrl 2.64 
Trt v Trt 0.25 
St. ctrl v Trt 5.16 
Syn. ctrl v Trt 2.77 
Key : St = Static cultures 
Sy = Synchronized cultwa 
Diff. in Pr. = DiffereDcc in Predicted values 
LSD = Least significant differencc 







Table 6. Statistical analysis of the results shown for isolate RSA 5 in Fig. 21. 
Comparison Diff. in Pro value LSD p-value 
Ctrl v Ctrl 0.79 1.23 NS 
Trt v Trt 0.06 1.54 NS 
st. ctrl v Trt 1.75 1.57 <0.05 
Syn. ctrl v Trt 2.48 1.19 <0.01 
Table 7. Statistical analysis of the results shown for isolate MW2 in Fig. 22. 
Comparison Diff. in Pr. value LSD p-value 
Ctrl v Ctrl 1.66 1.61 <0.05 
Trt v Trt 1.27 2.06 NS 
st. ctrl v Trt 1.34 1.21 <0.05 
Syn. ctrl v Trt 0.95 2.32 NS 
Key: 
St = Static cultures 
Sy = Synchroniud cultures 
Diff. in Pro = Difference in Predicted values 
LSD = Leut significant difference 
NS = not significant 
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Table 8. The statistical analysis of the results shown for isolate NF54 in Fig. 23. 
Comparison Diff. in Pro value LSD p-value 
Ctrl v Ctrl 1.61 
Trt v Trt 0.01 
St. ctrl v Trt 2.03 
Syn. ctrl v Trt 3.63 
Key: St = Static cultura 
Sy = Synchronized cultures 
Diff. in Pr. = Diff=nce in Predicted values 
LSD = Least significaut difference 






Table 9. The number of exflagellations counted in 40 microscopic fields for isolate 
RSA2. 
Time (Min) Static cultures Synchronized cultures 
Control Treated Control Treated 
15 11 10 14 10 
30 19 15 18 11 
45 24 17 25 16 
60 31 19 27 16 
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Table 10. The number of exflagellations counted in 40 microscopic fields for isolate 
RSA 5. 
Time (Min) Static cultures Synchronized cultures 
Control Treated Control Treated 
15 11 9 10 19 
:m 14 13 11 24 
45 16 15 19 31 
60 19 20 24 35 
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Fig. 24. Poisson regressions of the number of exflagellations counted m 40 
microscopic fields every 15 minutes for isolate RSA 2. 
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Fig. 25. Poisson regressions of the number of exflagellations counted in 40 
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5.4 DISCUSSION 
The morphology of the different stages of gametocytes in all five isolates treated with 
pyrimethamine was not affected, but their numbers were (Figs. 19-23). The immature 
gametocyte stages were affected by the drug which resulted in lower numbers of mature 
gametocytes in all the isolates (also the synchronized cultures of isolate RSA 2) (Appendix 
7). Tables 4-8 are confirming the statements above. There were no statistically significant 
differences within the static cultures of isolate RSA 2 between the control and treatment 
but there were significant differences within the synchronized cultures of the same isolate 
(p < 0.05). The differences were statistically significant between the control and the trial 
in the syncm:onized cultures of isolates RSA 3, 5 and NF54 at p < 0.01 each. Only in the 
synchronized cultures of isolate MW2 were the differences not significant. 
The differences in gametocyte numbers between the control and treatment in the static 
cultures of the four isolates, RSA 3, 5, MW2 and NF54 were significant at p-values of 
<0.001, <0.05, <0.05 and <0.01 respectively. NF54 was highly affected by the drug 
(Fig. 23). Firm conclusions cannot be made at this stage about the resistance of this isolate 
to pyrimethamine since the MIC of this isolate was not determined. The pyrimethamine 
concentration used in this study for NF54 could be higher than the MIC of this isolate, thus 
resulting in visible reaction to the drug. The results confirm reports on cited literature that 
pyrimethamine acts on young gametocytes of P. Jalciparum (Black et aI, 1986) and mature 
stages of gametocytes were not affected. This was expected as the drug does not act on 
mature gametocytes of this parasite (Desjardins et aI, 1988). Exflagellation was 
demonstrated by all the cultures of both RSA 2 and RSA 5 (Tables 9 and 10). 
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There were no statistically significant differences between the static and the synchronized 
cultures of RSA 2, but there were between control and the pyrimethamine-treated cultures 
of this isolate. There were also statistically significant differences between the static and 
synchronized cultures of RSA 5, but none between the control and the treated cultures of 
both the static and the synchronized cultures of this isolate. For RSA 5, pyrimethamine had 
no effect on exflagellation at the concentration of 3000nmol/ i. Pyrimethamine is known 
to be an effective sporontocide (Wernsdorfer, 1986). However, previous findings by 
Teldehaimanot et al (1985), showed that it had a sporontocidal effect against the strains 
whose asexual erythrocytic stages are sensitive to the drug but not on the strains whose 
asexual blood stages are pyrimethamine-resistant. They concluded that there might be a 
cross-resistant relationship between asexual and sexual stages of the parasites in the strains 
examined. Peters (1987) also confirmed these observations on pyrimethamine resistance. 
He found that pyrimethamine failed to prevent sporogony in two malaria patients and he 
suggested that pyrimethamine was not suitable for a malaria control campaign since P. 
jalciparum rapidly became resistant to it. 
It is difficult at this stage to make firm conclusions about the relationship between the 
sporontocidal effect of pyrimethamine and pyrimethamine resistance in southern African 
P. jalciparum since exflagellation was carried out on two isolates only. It would be 
interesting to investigate the sporontocidal effect of pyrimethamine on all 19 culture-
adapted southern African isolates of P. jalciparum available. Future investigations need to 
focus on the effect of pyrimethamine on oocyst development in vivo, the effect of other 
sporontocidal drugs such as proguanil, Fansidar and primaquine on gametocytes both in 
vitro and in vivo and their effects on infectivity in mosquitoes. 
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5.5 IMPLICATIONS FOR CONTROL OF MALARIA 
Pyrimethamine resistance is a problem common to all malarial areas of the world 
(Coosemans et ai, 1987; Petersen, 1987), including southern Africa (Freese et ai, 1991). 
Pyrimethamine has been resistance by P. Jalciparum has in fact been confmned at certain 
localities in all endemic regions including Africa (Black et ai, 1986). This pOses a huge 
problem for malaria control programmes since alternative drugs have to be developed. 
Pyrimethamine was used in combination with chloroquine in the hopes of interrupting 
malaria transmission. The results of this study indicate that pyrimethamine inhibits the 
development of gametocytes in vitro at concentrations that are inhibitory to the asexual 
parasites. However, previous studies have shown that southern African isolates have a wide 
range of MICs (Freese et ai, 1991) and it is possible that the serum pyrimethamine levels 
achieved by the standard prophylactic and treatment doses of Darachlor would not be 
sufficient to inhibit gametocyte development in vivo. 
CHAPTER 6 
ACTION OF CHLOROQUINE AND PYRIMETHAMINE, ALONE AND IN 




Chloroquine resistance is becoming common in southern Africa. Figures of 50% and 10% 
have been cited for Malawi (Newlands, 1989), and northern Namibia respectively (Isaacson 
et ai, 1984). In South Africa itself, a high number of cases in KwaZulu-Natal province are 
resistant (Freese et ai, 1988b, 1991; Herbst et ai, 1985, 1987). In South America, P. 
Jaiciparum was found to be resistant to chloroquine in Brazil, Colombia, French Guiana, 
Guyana and Suriname (Black et ai, 1986). Confrrmation of resistance to pyrimethamine 
in South Africa (refer to Chapter 5) means that the drug cannot be relied upon when used 
alone (McCutchan, 1988; Newlands, 1989). 
Drug combinations with pyrimethamine are thought to be more effective for chloroquine-
resistant malaria. Examples are Fansidar (pyrimethamine/sulphadoxine), Darachlor 
(pyrimethamine/chloroquine) and Maloprim (pyrimethamine/dapsone). The latter 
combination was found to be highly synergistic (Scott et ai, 1987). Although Fansidar 
resistance has been reported in some parts of the world (Hoffman et ai, 1987; Watt et ai, 
1987), it is still effective against the parasite in most areas where chloroquine-resistance 
has been reported (Desjardins et ai, 1988). 
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Multidrug resistance is posing another serious threat to malaria control schemes however 
and has been reported in various parts of the world, e.g. in Southeast Asia and South 
America (Desjardins et ai, 1988; Watt et ai, 1987; White, 1988). Fansidar was found to 
be effective for most patients with falciparum malaria in Indonesia (Hoffman et ai, 1987). 
The use of the combination of chloroquine and pyrimethamine was popular in the 1950s 
and 1960s for the treatment of overt malaria in semi-immune patients (Peters, 1987) and 
it has recently been reported that in certain areas this chloroquine/pyrimethamine 
combination was still effective (Peters, 1987). 
Previous studies have demonstrated the additive action of the chloroquine/pyrimethamine 
compound against the blood stages of P. berghei (Peters, 1987). The synergistic action 
between pyrimethamine and chloroquine has however not been investigated on the southern 
African isolates of P. Jalciparum. The aim of this study was to determine whether there 
was any synergism when these two drugs were used in combination. The study was 
relevant at the time it was carried out (1993) until recently (1994) when Darachlor was still 
the drug of choice in South Africa. 
6.2 MATERIALS AND METHODS 
The action of chloroquine and pyrimethamine alone and in combination on the asexual 
stages of P. Jalciparum was investigated following the methods described by Desjardins et 
al (1979) and Freese et al (1993) respectively. 
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6.2.1 Plasmodium Jalciparum Isolates 
Five southern African isolates of P. Jalciparum were used: two chloroquine-sensitive (RSA 
2 and 5) and three chloroquine-resistant; RSA 6, 9 and 14. The isolates were maintained 
in cultures as described previously in Chapter 3. For the drug tests, the cultures were 
diluted with fresh, washed, uninfected human type O-positive erythrocytes to a 
parasitaemia of 0.5-1 % and suspended to 4% in complete culture medium (Freese et ai, 
1993). 
6.2.2 Preparation of Drug Solutions 
Chloroquine and pyrimethamine were mixed in the following ftxed ratios of their 
approximate ICsos (concentrations required to inhibit 50% of parasite growth (Freese et ai, 
1993)): 1:1, 1:3 and 3:1 as follows: 
Chloroquine: Pyrimethamine (nM) 
1:1 1:3 3:1 
Isolate 
RSA 2 30:30 30:90 30:30 
RSA 3 10:2100 10:6300 30:2100 
RSA 5 10:2100 10:6300 30:2100 
RSA 6 150:60 150:180 450:60 
RSA 14 60:30 60:90 180:30 
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The above combinations were prepared at double strength from stock solutions. 
Chloroquine solution was prepared in distilled water and pyrimethamine solution in 0.05 % 
lactic acid. The drug combinations were then double-diluted six times in complete 
medium containing no hypoxanthine to yield seven dilutions of the drug combinations. For 
chloroquine alone, these concentrations (in nmoles) were prepared: 10, 20, 40, 80, 160, 
320 and 640. For pyrimethamine, the following concentrations (in nmol/ £) were prepared: 
6, 20, 60, 200, 600, 2000, 6000. 
6.2.3 In Vitro Test 
Each test was carried out in duplicate wells with the top row of a 96-well plate as control. 
On each plate there were two columns of chloroquine alone, two columns of 
pyrimethamine alone and two columns of each of the three fixed ratios of drug 
combination. To each well of a microtitre plate, 50JLi of a 4 % suspension of infected red 
blood cells at a 0.5-1 % parasitaemia and 50JLi of the drug or drug combination were added 
to yield a 2% suspension of infected red blood cells and the correct drug concentrations. 
The first row was the positive control and it contained no drug. The 11th column (wells 
C-H) were the negative controls and contained neither the drug nor the infected red blood 
cells only 2 % normal red blood cell suspension in culture medium. The plates were 
incubated at 38°C in a desiccator gassed with for 24 hours (Fig. 26). After the incubation 
period, 3H-hypoxanthine, 0.5JLCi in 10JLi culture medium, was added to each well of the 
microtitre plate. The plates were again gassed and incubated for a further 18 hours. 
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6.2.4 Harvesting and Scintillation Counting 
After the second incubation period, each plate was harvested on a Titertek cell harvester 
(Fig. 27). The contents of each well were aspirated and deposited onto small disks of glass 
fibre filter paper. The filter papers were then washed with distilled water and dried. The 
dried filter paper disks were placed in scintillation vials containing 4mi scintillation fluid 
and counted for 5 minutes in a Beckman LS 1800 liquid scintillation counter (Fig. 28). 
6.2.5 Data Analysis 
6.2.5.1 Calculation of ICsos 
The concentrations required to inhibit 50% parasite growth (ICsos) for chloroquine alone, 
pyrimethamine alone and for their combination, for each of the five isolates were 
calculated by method one of Freese et al (1993). Briefly, the two percentage growth 
(PCGROWTH) values closest to 50%, one on either side, were selected, assuming 
linearity between these two points. The concentration corresponding to 50% growth was 
then calculated by linear interpolation between the two points and their corresponding 
concentration values i.e. 
(Yl. - Y2) (Yl. - 50) 
(X2 - Xl.) (X3 - Xl.) 
or 
(Yl. - 50) 
X3 = X (X2 - Xl.) + Xl. 
(Yl. - Y2) 
where Yl and Y2 are the two PCGROWTH values closest to 50%, one on either side. Xl and 
X2 are their corresponding concentrations, and X3 is the concentration corresponding to 50% 
growth (ICso). 
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Fig. 27. Titertek Cell Harvester. 
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Fig. 28. Beckman LS 1800 Liquid Scintillation Counter. 
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The relative ICsos were then determined from the calculated ICsos by dividing the ICsos of 
each drug in combination by the ICso of the drug alone. The sum of the relative ICsos was 
used to denote the degree of synergism. If E relative ICso was smaller than one, synergistic 
action was indicated. When the sum equalled one the two drugs were additive, and when 
the sum was greater than one an antagonistic effect was indicated. Isobolograms were 
constructed by plotting the relative ICsos for chloroquine against the relative ICsos for 
pyrimethamine to show the synergistic effects of the two drugs (Martin et ai, 1987). 
Concave curves depict synergism between the two drugs and convex curves depict 
antagonism. 
6.2.5.2 Determination of the MICs 
The minimum inhibitory concentration (MIC) was defined as the lowest concentration at 
which growth of at least 95% of the parasites was inhibited. The mean of two counts per 
minute values (CPM) (of each isolate) corresponding to each drug concentration minus 
the mean of the six values corresponding to the negative control (non-parasitized 
erythrocytes) was expressed as a percentage of the control count. Taking the mean of the 
control count as 100 % growth (or 0% inhibition), the MIC for each isolate for 
chloroquine alone and pyrimethamine alone were determined. 
88 
6.3 RESULTS 
6.3.1. Chloroquine sensitivity 
The MICs and ICsos for chloroquine are presented in Table 11. The MICs obtained for 
chloroquine reflect the results obtained previously by Freese et al (1991) i.e. the 
chloroquine-sensitive strain (RSA 5) had an MIC < 160nmol/£ and the chloroquine-
resistant strains (RSA 6, 9 and 14) had MICs ~ 160nmol/£ (see Appendix 2). The 
comparison between the ICso values determined in this study and those obtained in previous 
studies is shown in Appendix 3. The MIC and the ICso values for RSA 2 isolate could not 
be determined since the range of concentrations used was too high to accommodate these 
values for this isolate. The ICso for RSA 5 of 13nmoll £ falls within the same range of 
concentrations as that obtained previously for chloroquine-sensitive isolates (Freese, 1994) 
using the radio-isotope incorporation method. Again, the ICso for isolate RSA 14 agrees 
well with that obtained by Freese (1994) using the radio-isotope incorporation method (see 
Appendix 3). Isolates RSA 6 and 9 have ICsos that are lower than those determined 
previously (Freese, 1994: Freese et ai, 1991). 
6.3.2 Pyrimethamine sensitivity 
The MIC and the ICso values of the isolates RSA 2, 6, 9 and 14 for pyrimethamine are 
also represented in Table 11. It was not possible to determine these values for RSA 5 from 
the data obtained. Comparisons of the MICs and ICsos obtained during this study and those 
obtained by Freese et al (1991) are shown in Appendices 4 and 5, respectively. The 
pyrimethamine MICs ranged from 300nmol/ £ to > 3000nmol/ £ . 
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Table 11. The minimum inhibitory concentrations (MICs) and ICsos for chloroquine 
and pyrimethamine (nM). 
CHLOROQUINE PYRIMETHAMINE 
Isolate MIC ICso MIC 
RSA 2 ND 36* >3000 
RSA 5 40 13 ND 
RSA 6 >320 44 300 
RSA 9 >320 69 300 
RSA 14 >320 70 300 
Note: Chloroquine - MIC ~ 160nmoll i, indicates resistance to the drug. 
- MIC ~ 160, sensitivity to the drug is indicated. 
Pyrimethamine - MIC ~ 100nmol/i, resistance to the drug is indicated. 
- MIC ~ 100nmoll i , sensitivity to the drug is indicated. 
ND - not determined 








They show a good agreement with the results obtained previously (Freese et ai, 1991) 
except for RSA 5 which failed to be inhibited at 3000nmol/£ (see Appendix 4). This MIC 
value is high compared to the pre-determined MIC of 100nmol/£ (Freese et ai, 1991) . The 
IC50s were all low compared to those obtained in previous drug sensitivity tests with the 
exception of RSA 2 which has an IC50 of 194nmol/£ when compared to 13nmol/£ of 
Freese et al (1991) (Appendix 5). The ICso for RSA 5 could not be determined because 
the range of concentrations used for this study could not accommodate the ICso for 
this isolate. 
6.3.3 Synergistic action of pyrimethamine with chloroquine 
It was possible to use the ICso value to determine the effect of pyrimethamine on the 
sensitivity of a particular isolate to chloroquine. Tables 12-16 give the ICsos and relative 
ICsos of the pyrimethamine/chloroquine combinations for RSA 2, 5, 6, 9 and 14 
respectively. The relative chloroquine ICsos for RSA 2 (Table 12) and the relative 
pyrimethamine ICsos for RSA 5 (Table 13) were calculated using previously determined 
chloroquine and pyrimethamine values indicated in Table 11 (Freese, 1994). The E relative 
ICsos for the fixed chloroquine/pyrimethamine ratios (Table 12) for RSA 2 ranged from 
0.609 to 1.794 and that for RSA 5 from 0.844 to 1.899 (Table 13) . Higher Es of relative 
ICsos are shown by the chloroquine-resistant isolates (Tables 14-16) . 
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Table 12. ICsos and relative ICsos for pyrimethamine/chloroquine combinations for 
isolate RSA 2. 
1 1 1 1
30:30 130:90 190:30 1 1 
ICso PYR ° 18,5 71 ,27 20,25 194,3 
(nM) 
CQ 36 18,5 23,76 60,77 ° 
Rei ICso PYR ° 0,095 0,367 0,104 1 
CQ 1 0,514 0,66 1,69 ° 
k DDEJEJEJD 
Table 13. ICsos and relative ICsos for pyrimethamine/chloroquine combinations for 
isolate RSA 5. 
I I I 
110:2100 110:6300 130:2100 
1 1 
ICso PYR ° 776 2295,48 807,27 1426 
(nM) 
CQ 12,45 3,7 3,65 11 ,53 ° 
Rei ICso PYR ° 0.544 1,609 0,566 1 
CQ 1 0.30 0,29 0,93 1 
k DDEJEJEJD 
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Table 14. ICsos and relative ICsos for pyrimethamine/chloroquine combinations for 
isolate RSA 6. 
1 1 1 1
150:60 1150:180 1450:60 1 1 
ICso PYR ° 13 ,9 33,42 11,79 9,11 
(nM) 
CQ 44,37 34,75 27,85 88,42 ° 
Rei ICso PYR ° 1,526 3,668 1,294 1 
CQ 1 0,783 0,628 1,99 ° 
L DDEJEJ~D 
Table 15. ICsos and relative ICsos for pyrimethamine/chloroquine combinations for 
isolate RSA 9. 
I I 1 
1150:60 1150:180 1450:60 
1 1 
IC.;o PYR 0 22,43 24,27 8,6 21,52 
(oM) 
69,24 56,1 20,23 64,53 CQ ° 
Rei ICso PYR ° 1,042 1,128 0,4 1 
CQ 1 0.81 0,292 0.932 ° 
L DDEJEJEJD 
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Table 16. ICsos and relative ICsos for pyrimethamine/chloroquine combinations for 
isolate RSA 14. 









ICso PYR 0 7,29 22,52 4,637 5,073 
(nM) 
CQ 70,06 14,59 15,02 27 ,82 0 
Rei ICso PYR 0 1,437 4,439 0,914 1 
CQ 1 0,208 0,214 0,397 0 
L DDEJEJEJD 
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Figures 29-33 are the isobolograms depicting the interaction between chloroquine and 
pyrimethamine (see Appendix 6 for explanation of the graphs) for isolates RSA 2, 5, 6, 
9 and 14 respectively. For RSA 2 and 5, the points on the graphs appear below and above 
the linear graph indicating no interaction. For RSA 6, 9 and 14, the points appear above 
the linear graph indicating an antagonistic interaction between the two drugs. The E relative 
ICsos for the most effective combination for the five isolates used are represented in Table 
17. RSA 2 and RSA 5 had the lowest E relative ICso (0.61 and 0.84 respectively). RSA 
6 had a lowest E relative ICso of 2.3 and the other two isolates (RSA 9 and 14) each had 
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Fig. 29. Isobologram showing the relationship between chloroquine and 
pyrimethamine of chloroquine-sensitive isolate RSA 2. 
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Fig. 30. Isobologram showing the relationship between chloroquine and 
pyrimethamine of chloroquine-sensitive isolate RSA 5. 
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Fig. 31. Isobologram showing the relationship between chloroquine and 
pyrimethamine of chloroquine-resistant isolate RSA 6. 
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Fig. 32. Isobologram showing the relationship between chloroquine and 
pyrimethamine of chloroquine-resistant isolate RSA 9. 
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Fig. 33. Isobologram showing the relationship between chloroquine and 
pyrimethamine of chloroquine-resistant isolate RSA 14. 
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Table 17. The sum of relative ICsos of the most effective drug combination for five 
isolates. 
ISOLATE CQ (nM) PYR (nM) SUMREL 
RSA 2 30 30 0,6 
RSA 5 10 2100 0,8 
RSA 6 150 30 2,3 
RSA 9 450 60 1,3 
RSA 14 180 30 1,3 
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6.4 DISCUSSION 
6.4.1 Antimalarial Activity 
The chloroquine MICs show good agreement with results obtained from previous drug 
sensitivity tests for all isolates using both the 48-hour in vitro test (Freese et ai, 1991) and 
growth assessment by isotope incorporation (Freese, 1994). The results indicate that RSA 
2 and 5 are chloroquine-sensitive and that RSA 6, 9 and 14 are chloroquine-resistant as 
described in previous studies (Freese et ai, 1988: 1991). The chloroquine IC50s of RSA 5 
and 14 are comparable with those determined by Freese et ai (1991) using the same method 
of growth assessment but not the IC50s of RSA 6 and 9 (Appendix 3). 
The pyrimethamine MICs ranged from 300nmol/ e to > 3000nmol/ £. The three isolates, 
all chloroquine-resistant (RSA 6, 9 and 14), were inhibited at 300nmol pyrimethamioe/£ 
and two chloroquine-sensitive (RSA 2 and 5) were not inhibited at 3000nmol 
pyrimethamine/ £. These results are consistent with those obtained previously by Freese et 
ai (1991). The pyrimethamine IC50s (Table 11) of RSA 6,9 and 14 are lower than those 
found hy Freese et ai (1991). The IC50 for RSA 2 is 194nmol/£ which is high compared 
to 31nmoll £ obtained in previous studies (Freese et ai, 1991). 
The pyrimethamine MICs and IC50s (Tahle 11) show greater variation when compared to 
those ohtained previously for the same isolates. This may he ascribed to the different 
methods used to determine the sensitivities. i.e. the isotope incorporation method used for 
this study and growth assessment hy microscopy in a 48-hour in vitro test used in previous 
investigations hy Freese et ai (1991). 
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The isotope incorporation method detects sensitivities at lower concentrations than the 48-
hour in vitro test (Freese et ai, 1991). However, the difference in these values is 
insignificant because of the wide range of pyrimethamine sensitivities that have been shown 
to occur amongst the southern African isolates of P. jalciparum (ranged from 10 to 
>3000nmoll£) (Freese et ai, 1991). 
The IC50 value is a more sensitive measure of drug susceptibility than the MIC value and 
it is possible that these values and to a lesser extent, the MIC values, are showing 
differences in the clonal make-up of the isolates at different times. In other words, the 
proportions of clones with different sensitivities in these isolates vary at different times of 
testing, resulting in different IC50 and MIC values (Freese et ai, 1991). Another 
explanation for these differences in MIC and IC50 values obtained at different times of 
testing is the possible cross-contamination of P. jalciparum cultures maintained in the 
laboratory (Robson et ai, 1992). To avoid cross-contamination between cultures, Robson 
et al (1992) suggested (1) that suitable markers should be identified for each laboratory line 
of parasites to allow monitoring at regular intervals, (2) that cloned isolates should be used 
for all laboratory studies and (3) that careful comparisons be made where the study 
involves drug resistance or antigen specificity. Results from characterization studies using 
southern African isolates of P. jalciparum (Freese, 1994) suggested that cross-
contamination may have occurred between these isolates. Recently Wooden et al (1993) 
developed a method for distinguishing P. jalciparum strains in the laboratory based on 
the polymerase chain reaction (PCR) technique. This method could be used to determine 
whether or not contamination has taken place within the bank of southern African isolates 
of P . ./alciparum. 
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6.4.2 Synergistic action of pyrimethamine with chloroquine 
The relationships between chloroquine and pyrimethamine are represented in Figs. 29-33 
(see Appendix 6 for explanation of the graphs) . Although the respective sums of relative 
IC50s for RSA 2 and RSA 5 (0.6 and 0.8 respectively) , (Table 17), indicate a weak 
synergism since it has been suggested (Hall et ai, 1983) that a weak synergism occurs 
when the value of E relative IC50 20.5, The graphs for the two chloroquine-sensitive 
isolates (RSA 2 and 5) clearly show no synergism between pyrimethamine and chloroquine. 
For the chloroquine-resistant isolates, RSA 6, 9 and 14, an antagonistic effect between the 
two drugs is indicated by Figs. 31-33 (refer to Appendix 6 for explanation of the graphs) 
and this is confirmed by their E relative IC50s which are all above 1.0 (1.3 each for RSA 
9 and 14 and 2.3 for RSA 6). It seems from these results, that the two drugs should not 
be used in combination, since an antagonistic action is exhibited. Although these results 
indicate an antagonistic action when chloroquine and pyrimethamine were used in 
combination, it has been reported that the two drugs had an additive effect on the blood 
stages of P. berghei (Peters, 1987) . 
6.5 CONCLUSION 
Previous work based on malaria chemotherapy contirmed the existence of chloroquine-
resistance parasites in South Africa. Herbst et al (1 985 , 1987) found that malaria patients 
from KwaZulu-Natal Province harboured chloroquine-resistant isolates of P. falciparum 
and that their levels of resistance to this drug were high. 
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These reports were later contirmed by Freese et al (1988) who reported high levels of 
chloroquine resistance at 232pmols per well in northern KwaZulu-Natal. From these 
findings there is absolutely no doubt that chloroquine resistant P. jalciparum malaria is a 
serious problem in southern Africa. The continuous discovery of chloroquine resistant 
malaria in southern Africa and world-wide show that this drug can no longer be relied upon 
on its own. 
The results of this and other studies indicate too that pyrimethamine, like chloroquine, is 
no longer useful for malaria prophylaxis on its own. Therefore, it is not surprising that the 
prescription of this drug is no longer recommended in this country. Although 
pyrimethamine resistance in southern Africa is not well documented, its resistance was 
discovered in many parts of the world as far back as the 1960s (Peters, 1987). These areas 
include many African countries like Gambia, Senegal, Ghana, Nigeria, Kenya and 
Tanzania as well as Malaya, India, Venezuela and many South American countries (Peters , 
1969). Resistance to pyrimethamine was also established in Pakistan and Thailand 
(Doberstyn et ai, 1979). These reports as well as the current one on the problem of drug 
resistance have serious implications for the control of malaria. 
Initially, chloroquine was used in combination with pyrimethamine and marketed as 
Darachlor apparently because of their additive effect. It was thought that chloroquine with 
its blood schizontocidal effect would work with pyrimethamine, which is both a slow 
schizontocide and a sporontocide, against P. falciparum (Peters, 1987). A second reason 
for the formulation of this compound was to delay the emergence of resistance to either of 
the drugs (Peters, 1987). 
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Although this combination was very popular in the 1950s and 1960s, it had neither an 
additive effect nor any impact on the emergence of resistance which became established in 
many parts of the world (Desjardins et ai, 1988; Peters, 1987). These present results 
confrrm the lack of positive interaction between pyrimethamine and chloroquine. Future 
research on the chemotherapy of malaria should focus on combinations of both new and 
old drugs in an attempt to enhance their activity and to delay the development of resistance. 
Since this study was carried out on only five of the 19 available southern African isolates 
of P. jalciparum, it would be valuable to investigate the action of pyrimethamine and 
chloroquine in combination on the remaining 13 isolates. 
The isobolograms representing the results from the two chloroquine-sensitive isolates (RSA 
2 and 5) show points on both sides of the middle line (Figs. 29-30) and those for the 
chloroquine-resistant isolates (RSA 6, 9 and 14), show points well above the midline (Figs. 
31-33). Firm conclusions cannot therefore be drawn on whether or not the combination of 
the two drugs is additive or an"tagonistic . More studies need to be carried out to confrrm 
the suggested antagonism but the interaction of the two drugs was definitely not synergistic. 
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CHAPTER 7 
IMPLICA TIONS FOR CONTROL OF MALARIA IN SOUTH AFRICA 
7.1 GAMETOCYTOCIDAL EFFECT 
The results from this investigation (see Chapter 5) indicate that pyrimethamine is still 
effective against the young stages of the gametocytes, thus preventing them from maturing. 
This confIrms statements made earlier by Black et at (1986) that the immature stages of 
gametocytes of P. Jatciparum are sensitive to the drug. In conclusion to the observations 
made from this study, it can be stated that pyrimethamine may have a role to play in South 
Africa. The drug may not be useful against the asexual parasites as reduced susceptibility 
has been established in vitro (Freese et ai, 1991), but it may be effective in blocking 
transmission by acting against the young gametocytes thereby decreasing the overall 
number of gametocytes. 
7.2 SPORONTOCIDAL EFFECT 
Pyrimethamine has been shown to inhibit the development of the sexual cycle of P. 
Jatciparum in the mosquitoes when administered to gametocyte carriers on whom the 
mosquitoes fed (Peters, 1987). Sinc~ this drug was effective against the developing 
mosquito stages it was known to playa role in interrupting transmission (Desjardins et at, 
1988). The results observed from gametocyte exflagellation showed that one isolate, RSA 
2. was affected by the drug at the previously determined MIC of 100nmol/f and the other, 
RSA 5 (at the MIC of 3000nmol/ f) was not affected. 
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Since exflagellation was not investigated in the chloroquine-resistant southern African 
isolates and the sporontocidal effect of pyrimethamine was not investigated in this study 
either, tirm conclusions cannot be made at this stage concerning the sporontocidal effect 
of pyrimethamine on these isolates. However, previous findings by Teklehaimanot et ai 
(1985) showed that pyrimethamine had a sporontocidal action against the isolates whose 
asexual erythrocytic stages are sensitive to the drug but no sporontocidal activity on the 
isolates that have resistant asexual stages resistant. This investigation led to conclusions that 
a cross-resistant relationship exists between asexual and sexual stages of the parasites 
(Teklehaimanot et ai, 1985). McCutchan (1988) also discovered that resistance to 
pyrimethamine was accompanied by resistance to their sporontocidal effect. 
Previous case studies confirm a lack of sporontocidal action of pyrimethamine on P. 
jalciparum resistant to the drug. Peters (1987) found that pyrimethamine failed to prevent 
sporogony in two malaria patients once resistance was established and that when repeated 
doses were administered to a Gambian baby, no effect was exerted on P. jalciparum. 
Resistance to pyrimethamine was not only established in P. jalciparum, but to other human 
species of Plasmodium as well. For example, a field study carried out in Venezuela showed 
that out of 15 cases that showed no response to pyrimethamine, 12 were associated with 
P. vivax and three with P. falciparum (Peters , 1987). Peters (1987) concluded that an 
increased dosage within tolerated limite;; will not help to improve the reduced parasite 
susceptihility if pyrimethamine is used on its own. 
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7.3 SYNERGISTIC EFFECT OF PYRIMETHAMINE AND CHLOROQUINE 
The use of the combined chloroquine/pyrimethamine was introduced with the hope that the 
antimalarial action would be increased and that theoretically, resistance development to the 
components would be delayed. Unfortunately, studies showed that there was neither a 
synergistic effect nor an additive action between the two drugs (Peters, 1987) and 
resistance to both chloroquine and pyrimethamine is widespread (Bjorkman & Phillips-
Howard, 1990; Wemsdorfer, 1991). The antagonistic etfect of pyrimethamine on 
chloroquine requires further investigation as these two drugs are still available in the 
country and their effectiveness might be diminished if used in combination. 
Until recently, the pyrimethamine/chloroquine combination was recommended for both 
prophylaxis and treatment in South Africa (Freese et ai, 1991). These authors suggested 
too that the continued used of this drug combination would result in an increased 
prevalence of resistance malaria and that this would stabilize the level of resistance to both 
chloroquine and pyrimethamine. Fear was expressed that the effectiveness of other 
pyrimethamine combinations might also be placed in jeopardy. Although resistance to the 
chloroquine/pyrimethamine combination was established in Ghana, amongst army personnel 
and their families, it was found to be useful in certain areas, e.g. in Haiti on a three-
weekly administration to malaria patients (Peters, 1987). Peters (1987) also reported that 
it was the massive deployment of pyrimethamine in association with chloroquine that was 
responsihle for the rapid spread of pyrimethamine resistance in P. falciparum almost world-
wide. 
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Prescription of this drug in South Africa alone or in combination with chloroquine may 
result in a regrettable experience because these results show that there was no synergistic 
action when pyrimethamine was used in combination with chloroquine. 
Pyrimethamine/chloroquine (Darachlor) is no longer recommended in South Africa since 
this drug combination has proved to have little effect on the parasites (Baker et ai, 1993). 
Growing drug resistance has serious implications since developing and researching new 
drugs involve expensive measures. 
The frequent monitoring for drug sensitivity should continue to be monitored both in vitro 
and in vivo where possible to prevent widespread resistance to other drug combinations 
with pyrimethamine such as Fansidar in South Africa. Freese et al (1994) suggested that 
continued monitoring of the susceptibility of P. Jalciparum is essential and that any current 
information involving drug sensitivity be made available to the general practitioners, health 
workers, drug policy makers and the malaria control personnel to ensure effective malaria 
control and treatment. 
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APPENDIX 1 
Statistical analysis of the results shown in Figs. 10-14 in Chapter 3. 
Isolate Compari·son Diff. 1n 
RSA 2 st vs Sy 0.5 
RSA 3 st vs Sy 2.65 
RSA 5 st vs Sy 0.79 
MW2 st vs Sy 1.66 
NF54 st vs Sy 1.61 
Key: st == Static cultures 
Sy == Synchronized cultures 
Dift. In Pr . = Difference in Predicted val ues 
LSD = Least significant difference 
NS = not significant 














Chloroquine sensitivity- MICs (nM) 
A B c 
Isolate 
RSA 2 NO 60 40 
RSA 5 40 100 20 
RSA 6 320* 300 320 
RSA 9 320* 600 320 
RSA 14 320* 600 160 
Key: A ~ results froa this study obtsined by Isotope incorporation method. 
B = results frcm previous study obtained by growth asses....,nt by mcroscopy in a 48-br in vin-o test. 
e ~ results froa previous study obtsined by growth aSSeBBIlent by isotope incorporation method. 
* = the isolate was not inhibited at this concentration . 
KD ~ not determined. 
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APPENDIX 3 
Chloroquine seositivity- Iesos (oM) 
A B c 
Isolate 
RSA 2 ND 36 30 
RSA 5 13 51 10 
RSA 6 44 122 140 
RSA 9 69 207 160 
RSA 14 70 255 60 
Key: It. = results froll this study obtained by Isotope i ncorporation method . 
B = results fra. previous study obtained by growth i!lssess-.ent by microscopy in a 48-hr In vitro t~t. 
C = results froll previous study obtained by growth assessaent by isotope incorporation method. 
NO = not deter:m.ined. 
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APPENDIX 4 
Pyrimethamine sensitivity- MICs (nM) 
A B 
Isolate 
RSA 2 3000* 100 
RSA 5 ND 3000 
RSA 6 300 100 
RSA 9 300 100 
RSA 14 300 100 
Key: 
A = results from this study obtained by I sotope i ncorporation method. 
S = r esults from previous study obtained by growth a s sesS.@ftt by .icroscopy in a 48-hr in vitro test • 
• = the isolate vas not inhibited. at this concentration. 
lID = not determined. 
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APPENDIX 5 
Pyrimethamine sensitivity- ICsos (nM) 
A 
Isolate 
RSA 2 194 
RSA 5 NO 
RSA 6 9 
RSA 9 22 
RSA 14 5 
Key: 
A ~ r esults from this s tudy obtained by Isotope 







S = results from previous study obtained by growth assessment by microscopy i n a 48-hr i n vitro test. 




An example of an isobologram. 
0 .2 0 .4 0 .6 0 .8 1 1.2 
PYR!METHAM!NE CONC (nM) 
~vnerat." Rtl" C - 1- .1ntagonl"cdl"C L ~ - , .. v, ~ Additive 
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APPENDIX 7 
Peak numbers of Stage II gametocyte counts per 10000 RBCs. 
Static cultures Synchronized cultures 
Isolate 
Control Trial Control Trial 
RSA 2 16 (8) 22 174 (1) 0 
RSA 3 36 (6) 0 45 (19) 0 
RSA 5 74 (7) 60 227 (9) 89 
MW2 33 (2) 11 20 (2) 0 
NF54 12 (9) 0 340 (6) 0 
Key: 
The numbers within brackets denote the days on which the peak was reached. 
